Harvard Bioscience

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Harvard Bioscience Inc

News

Press Releases

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Management

Harvard Bioscience Announces CFO Transition

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET

Earnings

Harvard Bioscience Announces First Quarter 2025 Financial Results

Harvard Bioscience Appoints John Duke to Board of Directors

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

HBIO

Applied DNA Sciences, Inc. - Common Stock

Applied DNA Sciences

Bionano Genomics

CDT Equity

Codexis

Champions Oncology

MindWalk Holdings

MaxCyte

Nautilus Biotechnology, Inc. - Common Stock

Nautilus Biotechnology

Inotiv

OmniAb

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Seer

Alpha Teknova

Benchmark

Comments

Harvard Bioscience

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL